REMEDIUM LIFECARE
|
REMEDIUM LIFECARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 15.07 | 2.99 | 1.33 | 0.77 | 0.02 |
| CEPS(Rs) | 0.55 | 0.11 | 0.05 | 0.03 | 0.01 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 28.79 | 13.72 | 10.72 | 9.32 | 8.55 |
| Tax Rate(%) | 26.63 | 29.33 | 26.41 | 26.13 | 58.33 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 1.41 | 0.36 | 0.80 | 13.42 | -43.18 |
| EBIT Margin(%) | 1.54 | 0.35 | 0.74 | 13.27 | 12.13 |
| Pre Tax Margin(%) | 1.45 | 0.30 | 0.73 | 12.97 | 12.07 |
| PAT Margin (%) | 1.06 | 0.21 | 0.53 | 9.58 | 5.03 |
| Cash Profit Margin (%) | 1.09 | 0.23 | 0.60 | 10.04 | 5.03 |
| Performance Ratios | |||||
| ROA(%) | 0.79 | 0.82 | 2.25 | 7.11 | 0.24 |
| ROE(%) | 70.92 | 24.51 | 13.33 | 8.62 | 0.26 |
| ROCE(%) | 102.54 | 18.16 | 7.39 | 11.16 | 0.62 |
| Asset Turnover(x) | 0.74 | 3.85 | 4.21 | 0.74 | 0.05 |
| Sales/Fixed Asset(x) | 1,909.86 | 1,621.56 | 339.30 | 11.83 | - |
| Working Capital/Sales(x) | 49.60 | 106.23 | 6.36 | 0.83 | 0.05 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | - | - | - | 0.08 | - |
| Receivable days | 84.61 | 31.70 | 51.05 | 103.36 | 2,487.09 |
| Inventory Days | 32.64 | 31.45 | 7.72 | 57.20 | 469.61 |
| Payable days | 77.15 | 54.31 | 50.25 | 80.60 | 1,426.41 |
| Valuation Parameters | |||||
| PER(x) | 48.94 | 46.26 | 32.97 | 28.98 | 695.95 |
| PCE(x) | 47.61 | 43.30 | 29.30 | 27.67 | 695.25 |
| Price/Book(x) | 25.62 | 10.10 | 4.11 | 2.39 | 1.81 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.48 | 0.10 | 0.28 | 2.58 | 28.66 |
| EV/Core EBITDA(x) | 30.47 | 26.52 | 35.05 | 18.83 | 236.23 |
| EV/EBIT(x) | 31.06 | 27.64 | 38.20 | 19.48 | 236.23 |
| EV/CE(x) | 0.21 | 0.22 | 0.66 | 1.75 | 1.29 |
| M Cap / Sales | 0.52 | 0.10 | 0.18 | 2.78 | 34.96 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 1.00 | 460.67 | 3,015.14 | 1,716.59 | -54.57 |
| Core EBITDA Growth(%) | 337.97 | 150.61 | 83.73 | 1,954.40 | 5.46 |
| EBIT Growth(%) | 347.82 | 162.10 | 74.33 | 1,886.53 | 14.20 |
| PAT Growth(%) | 403.44 | 124.31 | 73.47 | 3,362.50 | -41.18 |
| EPS Growth(%) | 403.44 | 124.31 | 73.47 | 3,365.97 | -41.24 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | 2.72 | 0.11 | 0.02 |
| Current Ratio(x) | 1.01 | 1.02 | 1.59 | 7.38 | 9.44 |
| Quick Ratio(x) | 1.00 | 0.64 | 1.46 | 6.10 | 8.89 |
| Interest Cover(x) | 17.46 | 7.72 | 43.12 | 45.64 | 193.00 |
| Total Debt/Mcap(x) | - | - | 0.66 | 0.05 | 0.01 |
Compare Financial Ratios of peers of REMEDIUM LIFECARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| REMEDIUM LIFECARE | ₹805.9 Cr | -18.5% | -32% | 13.7% | Stock Analytics | |
| ADANI ENTERPRISES | ₹328,377.0 Cr | 1.6% | -9.9% | 47.7% | Stock Analytics | |
| REDINGTON | ₹16,495.4 Cr | 1.1% | -4.9% | 22.4% | Stock Analytics | |
| HONASA CONSUMER | ₹13,803.1 Cr | -0.4% | 6.3% | NA | Stock Analytics | |
| MMTC | ₹10,354.5 Cr | -2.1% | -8.4% | 126.7% | Stock Analytics | |
| MSTC | ₹5,692.9 Cr | -1.8% | -11.1% | 165.9% | Stock Analytics | |
REMEDIUM LIFECARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| REMEDIUM LIFECARE | -18.5% |
-32% |
13.7% |
| SENSEX | -1.5% |
-2.6% |
17.8% |
You may also like the below Video Courses
